BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND KIF5B, ENSG00000170759, 3799, P33176, UKHC, KNS1, KNS, KINH
12 results:

  • 1. Comparative study of operative expenses: robotic vs. laparoscopic vs. open liver resections at a university hospital in the UK.
    Elshaer M; Askari A; Pathanki A; Rajani J; Ahmad J
    J Robot Surg; 2024 Jan; 18(1):12. PubMed ID: 38214790
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study.
    Xia H; Zhang J; Chen T; Wang M; Chen D; Si T; Liu Y
    Cancer Med; 2023 Jul; 12(13):14015-14024. PubMed ID: 37326363
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report.
    Wu L; Cheng Y; Huang D; Sun Y; Zhou C; Zhou J; Guo Y; Shao J; Zhang W; Lu S
    Anticancer Drugs; 2023 Oct; 34(9):1058-1064. PubMed ID: 37265026
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma.
    Wang WQ; Xu GY; Li J; Liang BY; Li J; Lin ML; Chen XP; Zhang EL; Huang ZY
    Cancer Med; 2023 Apr; 12(8):9627-9636. PubMed ID: 36847156
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of novel early pancreatic cancer biomarkers kif5b and SFRP2 from "first contact" interactions in the tumor microenvironment.
    Charles Jacob HK; Signorelli R; Charles Richard JL; Kashuv T; Lavania S; Middleton A; Gomez BA; Ferrantella A; Amirian H; Tao J; Ergonul AB; Boone MM; Hadisurya M; Tao WA; Iliuk A; Kashyap MK; Garcia-Buitrago M; Dawra R; Saluja AK
    J Exp Clin Cancer Res; 2022 Aug; 41(1):258. PubMed ID: 36002889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights.
    Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
    Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myc Regulation of a Mitochondrial Trafficking Network Mediates Tumor Cell Invasion and Metastasis.
    Agarwal E; Altman BJ; Ho Seo J; Bertolini I; Ghosh JC; Kaur A; Kossenkov AV; Languino LR; Gabrilovich DI; Speicher DW; Dang CV; Altieri DC
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31061095
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Selective RET kinase inhibition for patients with RET-altered cancers.
    Subbiah V; Velcheti V; Tuch BB; Ebata K; Busaidy NL; Cabanillas ME; Wirth LJ; Stock S; Smith S; Lauriault V; Corsi-Travali S; Henry D; Burkard M; Hamor R; Bouhana K; Winski S; Wallace RD; Hartley D; Rhodes S; Reddy M; Brandhuber BJ; Andrews S; Rothenberg SM; Drilon A
    Ann Oncol; 2018 Aug; 29(8):1869-1876. PubMed ID: 29912274
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Selective uptake by cancer cells of liposomes coated with polysaccharides bearing 1-aminolactose.
    Matsukawa S; Yamamoto M; Ichinose K; Ohata N; Ishii N; Kohji T; Akiyoshi K; Sunamoto J; Kanematsu T
    Anticancer Res; 2000; 20(4):2339-44. PubMed ID: 10953294
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.